vTv Therapeutics (VTVT) Earnings Date & Reports

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VTVT is expected to report earnings to fall 154.65% to -90 cents per share on August 12

vTv Therapeutics VTVT Stock Earnings Reports

Q2'26

Est.

$-0.90

Q1'26

Beat

by $2.71

Q3'25

Beat

by $0.42

Q2'25

Beat

by $0.20

Q1'25

Beat

by $0.33

The last earnings report on May 13 showed earnings per share of $1.65, beating the estimate of -105 cents. With 56.21K shares outstanding, the current market capitalization sits at 138.01M.

View a ticker or compare two or three

Compare

VTVT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for VTVT